LTX-315 is an oncolytic peptide with potent anticancer activity; inhibits MRC-5, A20 and AT84 with IC50s of 34.3, 8.3 and 11 μM, respectively.
CAT# | R1491 |
CAS | 1345407-05-7 |
Synonyms/Alias | K-K-W-W-K-K-W-Dip-K-NH2 |
M.F/Formula | C₇₈H₁₀₆N₁₈O₉ |
M.W/Mr. | 1439.79 |
Sequence | One Letter Code: KKWWKKW-Dip-K-NH2 three Letter Code: Lys-Lys-Trp-Trp-Lys-Lys-Trp-Dip-Lys-NH2 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Octreotide, a long-acting structural derivative of somatostatins, is a synthetic peptide analog of somatostatin with the same ...
What is abaloparatide? Abaloparatide (formerly known as BA058) is an investigational analog of human PTHrP (1-34) being devel ...
Corticotropin-releasing factor (CRF) is a 41 amino acid peptide that is an important hormone in the hypothalamic ...
The Discovery of Somatostatin Somatostatin (SS) is an endogenous peptide hormone isolated, purified and characterized in 1973 ...
Teicoplanin is a glycopeptide antibiotic developed after vancomycin for the treatment of Gram-positive (G+) cocc ...